50 related articles for article (PubMed ID: 34235995)
1. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Laliscia C; Gadducci A; Mattioni R; Orlandi F; Giusti S; Barcellini A; Gabelloni M; Morganti R; Neri E; Paiar F
Tumori; 2022 Aug; 108(4):376-385. PubMed ID: 34235995
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of FIGO staging defined by combining MRI and [
Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
[TBL] [Abstract][Full Text] [Related]
3. Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
Aoshika T; Noda SE; Abe T; Kumazaki YU; Hirai R; Igari M; Saito S; Ryuno Y; Iino M; Takeda Y; Ohta T; Watanabe J; Tsukahara K; Kato S
Anticancer Res; 2024 Apr; 44(4):1583-1589. PubMed ID: 38537975
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
Hua L; Wei M; Feng C; Li S; Wen X; Chen S
Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
[No Abstract] [Full Text] [Related]
5. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
[TBL] [Abstract][Full Text] [Related]
6. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
[TBL] [Abstract][Full Text] [Related]
7. From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.
Espenel S; Garcia MA; Trone JC; Guillaume E; Harris A; Rehailia-Blanchard A; He MY; Ouni S; Vallard A; Rancoule C; Ben Mrad M; Chauleur C; De Laroche G; Guy JB; Moreno-Acosta P; Magné N
Radiat Oncol; 2018 Feb; 13(1):16. PubMed ID: 29394940
[TBL] [Abstract][Full Text] [Related]
8. The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
Ohtaka T; Ando K; Oike T; Noda SE; Kaminuma T; Murata K; Ohno T
Front Oncol; 2024; 14():1366777. PubMed ID: 38774419
[TBL] [Abstract][Full Text] [Related]
9. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
[TBL] [Abstract][Full Text] [Related]
10. Utility of CT Radiomics and Delta Radiomics for Survival Evaluation in Locally Advanced Nasopharyngeal Carcinoma with Concurrent Chemoradiotherapy.
Huang YC; Huang SM; Yeh JH; Chang TC; Tsan DL; Lin CY; Tu SJ
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732355
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
Alarcón-Barrios S; Luvián-Morales J; Castro-Eguiluz D; Delgadillo-González M; Lezcano-Velázquez BO; Arango-Bravo EA; Flores-Cisneros L; Aguiar Rosas S; Cetina-Pérez L
Curr Probl Cancer; 2024 Feb; 48():101041. PubMed ID: 37988902
[TBL] [Abstract][Full Text] [Related]
12. Monocentric Retrospective Study: Efficacy, Feasibility, and Prognostic Factors of Single-Insertion High-Dose-Rate Brachytherapy With 4 Sessions for Locally Advanced Cervical Cancer.
Houdou L; Meynard C; Guillerm S; Mimoun C; Lambert T; Marchand E; Jornet D; Fumagalli I; Quero L; Huchon C; Hennequin C
Adv Radiat Oncol; 2024 Jul; 9(7):101512. PubMed ID: 38883995
[TBL] [Abstract][Full Text] [Related]
13. Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer.
Pan L; Shan RY; Gao SF; Zhou Y; Bao YY; Fu W
Technol Health Care; 2024; 32(2):823-830. PubMed ID: 37393459
[TBL] [Abstract][Full Text] [Related]
14. Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
Ladbury C; Eustace N; Kassardjian A; Amini A; Chen YJ; Wang E; Kohut A; Tergas A; Han E; Song M; Glaser S
Brachytherapy; 2024; 23(3):237-247. PubMed ID: 38553406
[TBL] [Abstract][Full Text] [Related]
15. Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
Halle MK; Hodneland E; Wagner-Larsen KS; Lura NG; Fasmer KE; Berg HF; Stokowy T; Srivastava A; Forsse D; Hoivik EA; Woie K; Bertelsen BI; Krakstad C; Haldorsen IS
Sci Rep; 2024 May; 14(1):11339. PubMed ID: 38760387
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
Parisi S; Sciacca M; Ferrantelli G; Chillari F; Critelli P; Venuti V; Lillo S; Arcieri M; Martinelli C; Pontoriero A; Minutoli F; Ercoli A; Pergolizzi S
Jpn J Radiol; 2024 Apr; 42(4):354-366. PubMed ID: 37987880
[TBL] [Abstract][Full Text] [Related]
17. Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
[TBL] [Abstract][Full Text] [Related]
18. Level of Concordance of Pre-, Intra-, and Postoperative Staging in Cervical Cancers (TREYA Study).
Toure M; Bambara AT; Kouassi KKY; Seka EN; Dia JM; Yao I; Kimso O; Adoubi I
J Oncol; 2017; 2017():8201462. PubMed ID: 29081801
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics -Based Nomogram.
Du W; Wang Y; Li D; Xia X; Tan Q; Xiong X; Li Z
Front Oncol; 2021; 11():637794. PubMed ID: 34322375
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenic Obesity in Cervical Carcinoma: A Strong and Independent Prognostic Factor beyond the Conventional Predictors (ESTHER Study-AFRAID Project).
Medici F; Ferioli M; Cammelli S; Forlani L; Laghi V; Ma J; Cilla S; Buwenge M; Macchia G; Deodato F; Vadalà M; Malizia C; Tagliaferri L; Perrone AM; De Iaco P; Strigari L; Bazzocchi A; Rizzo S; Arcelli A; Morganti AG
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
